| Nr. | Year OPEN | Title | users say | rate good | rate bad | no link | Citation |
|---|
Neoplasia (Tumor markers)Sialyl Lewis aNeuroblastomaColon and rectum (Neoplasia)Pleura (Effusion)Ovary (Neoplasia)Kidney (Neoplasm)| 1 | 2000 | Regular review: tumour markers in malignancies. | 
| + | - | nl | BMJ 320(7232):424-7 (2000) |
| 2 | 1972 | Foetal antigens and their role in the diagnosis and clinical management of human neoplasms: a review. |
| + | - | nl | Br J Cancer 26(5):335-55 (1972) |
| 3 | 1988 | Tumor markers in cancer diagnosis and prognosis. |
| + | - | nl | CA Cancer J Clin 38(2):104-26 (1988) |
| 4 | 2004 | Identification of human tumor antigens and its implications for diagnosis and treatment of cancer. |
| + | - | nl | Cancer Sci 95(10):784-91 (2004) |
| 5 | 2001 | Serological markers for detection of cancer (Review). |
| + | - | nl | Int J Mol Med 7(5):547-56 (2001) |
| 6 | 2008 | Cancer-associated antigens and antigen arrays in serological diagnostics of malignant tumors. |
| + | - | nl | Biochemistry (Mosc) 73(5):562-72 (2008) |
| 7 | 2007 | Carbohydrate antigen sialyl Lewis a--its pathophysiological significance and induction mechanism in cancer progression. |
| + | - | nl | Chang Gung Med J 30(3):189-209 (2007) |
| 8 | 2004 | A systematic review of molecular and biological tumor markers in neuroblastoma. |
| + | - | nl | Clin Cancer Res 10(1 Pt 1):4-12 (2004) |
| 9 | 2010 | A review of the most promising biomarkers in colorectal cancer: one step closer to targeted therapy. |
| + | - | nl | Oncologist 15(7):699-731 (2010) |
| 10 | 2005 | Diagnostic value of CYFRA 21-1, CEA, CA 19-9, CA 15-3, and CA 125 assays in pleural effusions: analysis of 116 cases and review of the literature. |
| + | - | nl | Oncologist 10(7):501-7 (2005) |
| 11 | 2010 | Plasma cell-free DNA in ovarian cancer: an independent prognostic biomarker. |
| + | - | nl | Cancer 116(8):1918-25 (2010) |
| 12 | 2009 | Tissue biomarkers in renal cell carcinoma: issues and solutions. |
| + | - | nl | Cancer 115(10 Suppl):2290-7 (2009) |
| 13 | 2002 | Practice guidelines for tumor marker use in the clinic. |
| + | - | nl | Clin Chem 48(8):1151-9 (2002) |
| 14 | 2010 | National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for use of tumor markers in liver, bladder, cervical, and gastric cancers. |
| + | - | nl | Clin Chem 56(6):e1-48 (2010) |
| 15 | 2009 | Serum tumor markers in oncology. |
| + | - | nl | Isr Med Assoc J 11(2):103-4 (2009) |
